We have shown that all of the above can be achieved in mesothelioma and lung cancer models either by vaccination with heat shocked autologous tumor [28] or intratumoral injection of IL-2 combined with anti-CD40 Ab, which avoids toxicity issues and induces regression of large primary tumors, as well as distal tumors [29]. This evidence concerns the gene CD40 and neoplasm.